AMENDMENT TO CLINICAL SERVICES AGREEMENTClinical Services Agreement • March 31st, 1999 • Alteon Inc /De • Pharmaceutical preparations
CLINICAL SERVICES AGREEMENTClinical Services Agreement • August 21st, 2015 • Advanced Accelerator Applications S.A. • Pharmaceutical preparations
THIS CLINICAL SERVICES AGREEMENT (together with all corresponding Exhibits, "AGREEMENT") is entered into as the 1st of November 2011 by and between Advanced Accelerator Applications, with registered office in Saint-Genis-Pouilly, 20 rue Diesel, France ("SPONSOR"), and Pierrel Research Italy Spa ("CRO"), with registered office in Via Pietro Mascagni 14, Milan, Italy and operational offices in Italy, in Sesto S. Giovanni (MI), Via Alberto Falck 15 and in Cantù (CO), Via Como 5.
Horizon Health Services - Clinical Services AgreementClinical Services Agreement • November 17th, 2020
In coming for treatment at Horizon, you have established an important partnership designed to help you meet your or your child/family member’s recovery goals. This partnership involves you and your doctor/nurse practitioner, counselors, other professionals, family members and significant others, medical providers, and the individuals or agencies who referred you. Communication and cooperation among these parties, and your full participation, will be important to your recovery and treatment success, including your:
CLINICAL SERVICES AGREEMENTClinical Services Agreement • July 26th, 2024
Welcome to Sunflower Pediatric Behavioral Health. This document contains important information about professional services and office business policies. Psychological and psychiatric services involve a commitment of time and resources, so it is important that you are careful about selecting providers who are the best fit for your family. If you have any questions about our services, please feel free to discuss them at any time.
Clinical Services Agreement and Consent FormClinical Services Agreement • May 13th, 2013
Welcome. This document contains important information about my professional services and business policies. It also contains summary information about the Health Insurance Portability and Accountability Act (HIPAA), a federal law that provides new privacy protections and new client rights with regard to the use and disclosure of your Protected Health Information (PHI) used for the purpose of treatment, payment, and health care operations. HIPAA requires that I provide you with a Notice of Privacy Practices (the Notice) for use and disclosure of PHI for treatment, payment and health care operations. The Notice, which is available on my website, explains HIPAA and its application to your personal health information in greater detail. The law requires that I obtain your signature acknowledging that I have provided you with this information.
Contract to offer paid services of a clinical nature outside program sanctioned practicum hoursClinical Services Agreement • October 25th, 2023
*The clinical supervisor must be a certified, licensed or registered psychologist in good standing with the College of Psychologists of Ontario.
THE SYMBOL “[****]” DENOTES PLACES WHERE PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. SUCH MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. Amendment #4 to Clinical...Clinical Services Agreement • February 26th, 2015 • RedHill Biopharma Ltd. • Pharmaceutical preparations
This Change Order 4 (“Change Order”) to the Clinical Services Agreement signed 15 June 2011 (“Clinical Services Agreement”), is by and among:
Amendment 2 to Clinical Services Agreement Sponsor’s study drug RHB-104Clinical Services Agreement • July 7th, 2014 • RedHill Biopharma Ltd. • Pharmaceutical preparations
This Change Order constitutes an amendment to the Clinical Services Agreement pursuant to section 3.0 therein. As such, this Change Order is subject in all respects to the terms and provisions of the Clinical Services Agreement.
CLINICAL SERVICES AGREEMENT BETWEENClinical Services Agreement • September 21st, 2021 • Georgia
This CLINICAL SERVICES AGREEMENT ("Agreement") is made and entered into this 5th day of October 2021 (the "Effective Date") by and between WALTON COUNTY, GEORGIA, a political subdivision of the State of Georgia (the "County") and THE BOARD OF REGENTS OF THE UNIVERSITY SYSTEM OF GEORGIA BY AND ON BEHALF OF UNIVERSITY HEAL TH CENTER PHARMACY (the "Institution").
Change Order 7 to Clinical Services AgreementClinical Services Agreement • February 23rd, 2017 • RedHill Biopharma Ltd. • Pharmaceutical preparations
This Change Order 7 (“Change Order”) to the Clinical Services Agreement signed 15 June 2011 (“Clinical Services Agreement”), is by and among:
CLINICAL SERVICES AGREEMENT BETWEENClinical Services Agreement • August 30th, 2022 • Georgia
This CLINICAL SERVICES AGREEMENT ("Agreement") is made and entered into this 22th day of August 2022 (the "Effective Date") by and between WALTON COUNTY, GEORGIA, a political subdivision of the State of Georgia (the "County") and THE BOARD OF REGENTS OF THE UNIVERSITY SYSTEM OF GEORGIA BY AND ON BEHALF OF UNIVERSITY HEALTH CENTER PHARMACY (the "Institution").
ContractClinical Services Agreement • March 29th, 2017 • Advanced Accelerator Applications S.A. • Pharmaceutical preparations
In response to a request from your Head of Legal Cécile Meynet, this letter is intended to clarify the status of the Clinical Services Agreement (the “Agreement”) between Advanced Accelerator Applications (hereafter to be referred to as “Sponsor”) and Accelovance Europe S.r.l. (hereinafter to be referred to as “Accelovance”) with respect to the clinical trial known as, “A multicenter, stratified, open, randomized, comparator-controlled, paral lel groups phase III study comparing treatment with 177Lu-DOTAO-Tyr3-Octreotate to Octreotide LAR in patients with inoperable, progressive, somatostatin receptor positive midgut carcinoid tumours” (the “Study”). The initial Agreement was entered into by Pierrel Research Italy Spa on 1 November 2011.
between [INSERT NAME OF HOSPITAL AND HEALTH SERVICE] and [INSERT NAME OF VMO] for the provision of CLINICAL SERVICESClinical Services Agreement • May 5th, 2020 • Queensland
EMILY GRIFFIN, M.A., LCPCClinical Services Agreement • November 7th, 2020
CLINICAL SERVICES AGREEMENTClinical Services Agreement • January 17th, 2020
Horizon Health Services - Clinical Services AgreementClinical Services Agreement • February 9th, 2023
Our mission is to provide high quality, comprehensive and evidence-based care that is based on your individual needs and reasons for seeking treatment. We also believe that recovery is a continual process, and that the involvement of family and significant others is often critical to treatment success.
CLINICAL SERVICES AGREEMENTClinical Services Agreement • January 28th, 2008 • Derma Sciences, Inc. • Surgical & medical instruments & apparatus • California
THIS CLINICAL SERVICES AGREEMENT (“Agreement”) is made and entered into this ____ day of January, 2008 by and between Derma Sciences, Inc., a corporation organized under the laws of the Commonwealth of Pennsylvania and headquartered in Princeton, New Jersey (“Derma Sciences”) and U.S. Biotest, Inc., a corporation organized under the laws of the State of California and headquartered in San Luis Obispo, California (“Biotest”).
THE SYMBOL "[****]" DENOTES PLACES WHERE PORTIONS OF THIS DOCUMENT HAVE BEEN OMIITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. SUCH MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION Change Order 5.1 to Clinical...Clinical Services Agreement • February 23rd, 2017 • RedHill Biopharma Ltd. • Pharmaceutical preparations
This Change Order 5.1 (“Change Order”) to the Clinical Services Agreement signed 15 June 2011 (“Clinical Services Agreement”), is by and among:
ContractClinical Services Agreement • February 25th, 2014 • RedHill Biopharma Ltd. • Pharmaceutical preparations
THE SYMBOL “[****]” DENOTES PLACES WHERE PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. SUCH MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.
FIRST ADDENDUMClinical Services Agreement • February 20th, 2014
This FIRST ADDENDUM (ADDENDUM) is entered into as of January 1, 2014 by and between the UNIVERSITY OF KENTUCKY (“UNIVERSITY”) and the HAZARD INDEPENDENT SCHOOLS BOARD OF EDUCATION (“CONTRACTING PARTY”) (each a “Party” and
Changed Order 4.1 to Clinical Services Agreement Sponsor’s study drug RHB-104Clinical Services Agreement • February 25th, 2016 • RedHill Biopharma Ltd. • Pharmaceutical preparations
FIRST ADDENDUMClinical Services Agreement • February 20th, 2014
This FIRST ADDENDUM (ADDENDUM) is entered into as of January 1, 2014 by and between the UNIVERSITY OF KENTUCKY (“UNIVERSITY”) and the HAZARD INDEPENDENT SCHOOLS BOARD OF EDUCATION (“CONTRACTING PARTY”) (each a “Party” and
School Board Meeting Notes 8.6.20Clinical Services Agreement • August 6th, 2020
Here are a few things for you to know from the August 6 board meeting. You can find materials from the school board meeting and an archived video of the meeting online.
CLINICAL SERVICES AGREEMENT This CLINICAL SERVICES AGREEMENT (this “ Agreement ”) is made effective as of the date of last signature below (the “ Effective Date ”) by and between Labcorp Drug Development Inc . with a place of business at 10 Moore...Clinical Services Agreement • July 31st, 2023 • Portage Biotech Inc. • Crude petroleum & natural gas
Horizon Health Services - Clinical Services AgreementClinical Services Agreement • May 3rd, 2021
Our mission is to provide high quality, comprehensive and evidence-based care that is based on your individual needs and reasons for seeking treatment. We also believe that recovery is a continual process, and that the involvement of family and significant others is often critical to treatment success.
CLINICAL SERVICES AGREEMENTClinical Services Agreement • March 14th, 2008 • Inspire Pharmaceuticals Inc • Pharmaceutical preparations • North Carolina
Clinical Services Agreement and Consent Form Dr. Teresa SztabaClinical Services Agreement • February 16th, 2024
Welcome! This document contains important information about our professional services and business policies. Please understand that not all of the services described in this document may apply to you and the services that we have agreed to provide to you/your family. Additional information can be found on our website, drsztaba.com.
Amendment 3 to Clinical Services Agreement Sponsor’s study drug RHB-104Clinical Services Agreement • February 26th, 2015 • RedHill Biopharma Ltd. • Pharmaceutical preparations
This Amendment 3 (“Change Order”) to the Clinical Services Agreement signed 15 June 2011 (“Clinical Services Agreement”), is by and among:
Clinical Services Agreement and Consent FormClinical Services Agreement • August 12th, 2021
Welcome. This document contains important information about my professional services and business policies. Please understand that not all of the services described in this document may apply to you and the services that I have agreed to provide to you/your family. Details regarding the Personal Information Protection and Electronic Documents Act (PIPEDA), a federal law that provides privacy protections and client rights with regard to the use and disclosure of all personal data, including personal health information (PHI), is available at https://www.priv.gc.ca/en/privacy-topics/privacy-laws-in-canada/the- personal-information-protection-and-electronic-documents-act-pipeda/ . The law requires an individual’s consent for the collection, use, or disclosure of personal health information.
Horizon Health Services - Clinical Services AgreementClinical Services Agreement • January 27th, 2022
Our mission is to provide high quality, comprehensive and evidence-based care that is based on your individual needs and reasons for seeking treatment. We also believe that recovery is a continual process, and that the involvement of family and significant others is often critical to treatment success.
Change Order 5 to Clinical Services Agreement Client’s study drug RHB-104Clinical Services Agreement • February 25th, 2016 • RedHill Biopharma Ltd. • Pharmaceutical preparations
This Change Order 5 (“Change Order”) to the Clinical Services Agreement signed 15 June 2011 (“Clinical Services Agreement”), is by and among:
AGREEMENT FOR CLINICAL SERVICESClinical Services Agreement • January 27th, 2021 • Georgia
As a cooperative activity in the education of EMT students of Hall County Fire Services (hereinafter referred to as the “Department’ or HCFS), the clinical site known as:
COUNTY COMMISSIONERSClinical Services Agreement • January 16th, 2018 • Kansas
ContractClinical Services Agreement • May 5th, 2020 • Delaware
EX-10.24 2 ex10-24.htm CLINICAL SERVICES AGREEMENT WITH ONCOTHERAPEUTICS EXHIBIT 10.24 AGREEMENT FOR CLINICAL SERVICES THIS AGREEMENT, dated as of the Sixth day of December 2010, is by and among CytRx Corporation, (“CytRx ” or “SPONSOR”), with offices located at 11726 San Vicente Boulevard, Suite 650, Los Angeles, California 90049, and Oncotherapeutics (“Oncotherapeutics” or “CRO”), with offices located at 9201 Sunset Boulevard, Suite 317, West Hollywood, CA 90069. WHEREAS, CytRx Corporation, a corporation organized and existing under the laws of the State of Delaware, is engaged in the discovery, development and marketing of pharmaceutical products; and WHEREAS, Oncotherapeutics, a corporation organized and existing under the laws of the State of California is a contract research organization engaged in the business of managing and monitoring clinical trials and analyzing clinical research data for pharmaceutical products; and WHEREAS, CRO desires to assist SPONSOR in organizing, moni
Clinical Services AgreementClinical Services Agreement • November 7th, 2020
Welcome to my practice! I am looking forward to working with you. This document contains important information about my professional services and business practices. Please read it carefully and ask me any questions. It notifies you of many of your rights and responsibilities and will represent an agreement between us.
